1. Executive Summary 2. Giant-Cell Arteritis Market Characteristics
3. Giant-Cell Arteritis Market Trends And Strategies
4. Giant-Cell Arteritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Giant-Cell Arteritis Growth Analysis And Strategic Analysis Framework
5.1. Global Giant-Cell Arteritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Giant-Cell Arteritis Market Growth Rate Analysis
5.4. Global Giant-Cell Arteritis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Giant-Cell Arteritis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Giant-Cell Arteritis Total Addressable Market (TAM)
6. Giant-Cell Arteritis Market Segmentation
6.1. Global Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Methotrexate
Tocilizumab
Aspirin
6.2. Global Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Immunosuppressive Agents
Anticoagulants
Other Mechanisms Of Action
6.3. Global Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
Other Routes Of Administration
6.4. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Prednisone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Prednisone
Intravenous (IV) Prednisone
Low-Dose Prednisone Therapy
High-Dose Prednisone Therapy
6.5. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Methotrexate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Methotrexate
Subcutaneous Methotrexate
Methotrexate Monotherapy
Methotrexate Combination Therapy
6.6. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Tocilizumab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Tocilizumab
Subcutaneous Tocilizumab
Tocilizumab Monotherapy
Tocilizumab In Combination With Corticosteroids
6.7. Global Giant-Cell Arteritis Market, Sub-Segmentation Of Aspirin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low-Dose Aspirin Therapy
Aspirin For Cardiovascular Risk Management
Aspirin In Combination Therapy
Enteric-Coated Aspirin
7. Giant-Cell Arteritis Market Regional And Country Analysis
7.1. Global Giant-Cell Arteritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Giant-Cell Arteritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Giant-Cell Arteritis Market
8.1. Asia-Pacific Giant-Cell Arteritis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Giant-Cell Arteritis Market
9.1. China Giant-Cell Arteritis Market Overview
9.2. China Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Giant-Cell Arteritis Market
10.1. India Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Giant-Cell Arteritis Market
11.1. Japan Giant-Cell Arteritis Market Overview
11.2. Japan Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Giant-Cell Arteritis Market
12.1. Australia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Giant-Cell Arteritis Market
13.1. Indonesia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Giant-Cell Arteritis Market
14.1. South Korea Giant-Cell Arteritis Market Overview
14.2. South Korea Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Giant-Cell Arteritis Market
15.1. Western Europe Giant-Cell Arteritis Market Overview
15.2. Western Europe Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Giant-Cell Arteritis Market
16.1. UK Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Giant-Cell Arteritis Market
17.1. Germany Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Giant-Cell Arteritis Market
18.1. France Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Giant-Cell Arteritis Market
19.1. Italy Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Giant-Cell Arteritis Market
20.1. Spain Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Giant-Cell Arteritis Market
21.1. Eastern Europe Giant-Cell Arteritis Market Overview
21.2. Eastern Europe Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Giant-Cell Arteritis Market
22.1. Russia Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Giant-Cell Arteritis Market
23.1. North America Giant-Cell Arteritis Market Overview
23.2. North America Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Giant-Cell Arteritis Market
24.1. USA Giant-Cell Arteritis Market Overview
24.2. USA Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Giant-Cell Arteritis Market
25.1. Canada Giant-Cell Arteritis Market Overview
25.2. Canada Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Giant-Cell Arteritis Market
26.1. South America Giant-Cell Arteritis Market Overview
26.2. South America Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Giant-Cell Arteritis Market
27.1. Brazil Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Giant-Cell Arteritis Market
28.1. Middle East Giant-Cell Arteritis Market Overview
28.2. Middle East Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Giant-Cell Arteritis Market
29.1. Africa Giant-Cell Arteritis Market Overview
29.2. Africa Giant-Cell Arteritis Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Giant-Cell Arteritis Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Giant-Cell Arteritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Giant-Cell Arteritis Market Competitive Landscape And Company Profiles
30.1. Giant-Cell Arteritis Market Competitive Landscape
30.2. Giant-Cell Arteritis Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Giant-Cell Arteritis Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb Company
31.4. Novartis AG
31.5. GlaxoSmithKline Plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Amgen Inc.
31.9. Boehringer Ingelheim
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Regeneron Pharmaceuticals Inc.
31.12. Astellas Pharma Inc.
31.13. CSL Limited
31.14. Kiniksa Pharmaceuticals Ltd.
31.15. MorphoSys AG
32. Global Giant-Cell Arteritis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Giant-Cell Arteritis Market
34. Recent Developments In The Giant-Cell Arteritis Market
35. Giant-Cell Arteritis Market High Potential Countries, Segments and Strategies
35.1 Giant-Cell Arteritis Market In 2029 - Countries Offering Most New Opportunities
35.2 Giant-Cell Arteritis Market In 2029 - Segments Offering Most New Opportunities
35.3 Giant-Cell Arteritis Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer